127 related articles for article (PubMed ID: 20505538)
1. Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms' tumor: a meta-analysis.
Presson A; Moore TB; Kempert P
J Pediatr Hematol Oncol; 2010 Aug; 32(6):454-61. PubMed ID: 20505538
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
Campbell AD; Cohn SL; Reynolds M; Seshadri R; Morgan E; Geissler G; Rademaker A; Marymount M; Kalapurakal J; Haut PR; Duerst R; Kletzel M
J Clin Oncol; 2004 Jul; 22(14):2885-90. PubMed ID: 15254057
[TBL] [Abstract][Full Text] [Related]
3. Salvage treatment of relapsing Wilms' tumour by autologous bone marrow transplantation.
Kullendorff CM; Békássy AN
Eur J Pediatr Surg; 1997 Jun; 7(3):177-9. PubMed ID: 9241510
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response.
Brown E; Hebra A; Jenrette J; Hudspeth M
J Pediatr Hematol Oncol; 2010 Aug; 32(6):e241-3. PubMed ID: 20628317
[TBL] [Abstract][Full Text] [Related]
5. Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor.
Maurer K; Heitger A; Schwaighofer H; Fink FM; Niederweiser D
Bone Marrow Transplant; 1997 Dec; 20(12):1111-3. PubMed ID: 9466289
[TBL] [Abstract][Full Text] [Related]
6. High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study.
Hempel L; Kremens B; Weirich A; Graf N; Zintl F; Ludwig R
Klin Padiatr; 1996; 208(4):186-9. PubMed ID: 8776705
[TBL] [Abstract][Full Text] [Related]
7. Current challenges in Wilms' tumor management.
Gommersall LM; Arya M; Mushtaq I; Duffy P
Nat Clin Pract Oncol; 2005 Jun; 2(6):298-304; quiz 1 p following 324. PubMed ID: 16264987
[TBL] [Abstract][Full Text] [Related]
8. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F; Bisogno G; Collini P; Jenkner A; Gandola L; D'Angelo P; Casazza G; Piva L; Luksch R; Perotti D; Pession A; Fagioli F; Dallorso S
Pediatr Blood Cancer; 2008 Jul; 51(1):23-8. PubMed ID: 18293386
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor: Re-evaluating outcomes.
Rossoff J; Tse WT; Duerst RE; Schneiderman J; Morgan E; Kletzel M; Chaudhury S
Pediatr Hematol Oncol; 2018; 35(5-6):316-321. PubMed ID: 30681039
[TBL] [Abstract][Full Text] [Related]
10. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
11. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
[TBL] [Abstract][Full Text] [Related]
12. Incidence and outcomes of patients with late recurrence of Wilms' tumor.
Malogolowkin M; Spreafico F; Dome JS; van Tinteren H; Pritchard-Jones K; van den Heuvel-Eibrink MM; Bergeron C; de Kraker J; Graf N;
Pediatr Blood Cancer; 2013 Oct; 60(10):1612-5. PubMed ID: 23737480
[TBL] [Abstract][Full Text] [Related]
13. Megatherapy in the treatment of high-risk relapsed Wilms tumor.
Valera ET; Cristófani L; Scrideli CA; Duarte RJ; Filho VO; Tone LG
Pediatr Blood Cancer; 2004 Aug; 43(2):186-8. PubMed ID: 15236294
[No Abstract] [Full Text] [Related]
14. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor: a 10 year retrospective study.
Seyed-Ahadi MM; Khaleghnejad-Tabari A; Mirshemirani A; Sadeghian N; Amonollahi O
Arch Iran Med; 2007 Jan; 10(1):65-9. PubMed ID: 17198457
[TBL] [Abstract][Full Text] [Related]
16. An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour.
Ha TC; Spreafico F; Graf N; Dallorso S; Dome JS; Malogolowkin M; Furtwängler R; Hale JP; Moroz V; Machin D; Pritchard-Jones K
Eur J Cancer; 2013 Jan; 49(1):194-210. PubMed ID: 22959164
[TBL] [Abstract][Full Text] [Related]
17. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
[TBL] [Abstract][Full Text] [Related]
18. Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.
Dome JS; Liu T; Krasin M; Lott L; Shearer P; Daw NC; Billups CA; Wilimas JA
J Pediatr Hematol Oncol; 2002; 24(3):192-8. PubMed ID: 11990305
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
